Apixaban
37 views | +0 today
Follow
Apixaban
Apixaban News:  Exemplary news revealed on July 1, 2013 that Apixaban, known as the brand name Eliquis, had achieved its primary goal in studies and proved to be an effective anticoagulant.  Apixaban not only matched standard treatments for potentially fatal blood clots, but it was also deemed efficacious and safe.  When compared to its competitor anticoagulant warfarin, Apixaban had a better safety profile, showing a 69 percent risk reduction for major bleeding events.  Apixaban was initially approved on December 31, 2012 by the FDA to help reduce the risk of blood clots and stroke in patients who have atrial fibrillation that is not caused by a heart valve problem.
Curated by LGM Pharma
Your new post is loading...
Your new post is loading...
Scooped by LGM Pharma
Scoop.it!

U.S. FDA Approves Eliquis® (apixaban) To Reduce The Risk Of Blood Clots Following Hip Or Knee Replacement Surgery | Pfizer Pharmaceutical News and Media | Pfizer: the world's largest research-based...

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that the U.S.
more...
No comment yet.
Scooped by LGM Pharma
Scoop.it!

New Data Touts Value of Apixaban - LGM Pharma Blog

New Data Touts Value of Apixaban - LGM Pharma Blog | Apixaban | Scoop.it
Results from from a recently released study coined AMPLIFY were positive, indicating that Apixaban was efficacious and safe.
more...
No comment yet.
Scooped by LGM Pharma
Scoop.it!

Sanofi profits plunge but forecasts strong second half - PharmaTimes

Sanofi profits plunge but forecasts strong second half - PharmaTimes | Apixaban | Scoop.it
Sanofi profits plunge but forecasts strong second half
PharmaTimes
...
more...
No comment yet.
Scooped by LGM Pharma
Scoop.it!

CSL Behring Receives FDA Approval of Kcentra™ for Urgent Warfarin Reversal in Patients with Acute Major Bleeding

KING OF PRUSSIA, Pa., April 30, 2013 /PRNewswire/ -- CSL Behring announced today that the U.S. Food and...
more...
No comment yet.
Scooped by LGM Pharma
Scoop.it!

CSL Behring Receives FDA Approval of Kcentra(TM) for Urgent Warfarin Reversal in Patients with Acute Major BleedingEmployer News: Pharma diversity job board - diversity job board, pharmaceutical jobs

CSL Behring Receives FDA Approval of Kcentra(TM) for Urgent Warfarin Reversal in Patients with Acute Major BleedingEmployer News: Pharma diversity job board - diversity job board, pharmaceutical jobs | Apixaban | Scoop.it
CSL Behring Receives FDA Approval of Kcentra(TM) for Urgent Warfarin Reversal in Patients with Acute Major BleedingEmployer News: PharmaDiversity Job Board is a Global Job Board featuring Companies with a commitment to diversity hiring all around...
more...
No comment yet.
Scooped by LGM Pharma
Scoop.it!

Is Apixaban the Next New Anticoagulant? - LGM Pharma Blog

Is Apixaban the Next New Anticoagulant? - LGM Pharma Blog | Apixaban | Scoop.it
These combined studies offered exceptional results for the potential use of Apixaban in stroke prevention for patients w/ atrial fibrillation
more...
No comment yet.
Scooped by LGM Pharma
Scoop.it!

FDA approves drug for urgent warfarin reversal - Clinical Advisor

FDA approves drug for urgent warfarin reversal - Clinical Advisor | Apixaban | Scoop.it
Medscape FDA approves drug for urgent warfarin reversal Clinical Advisor HealthDay News -- The FDA has approved the first non-activated 4-factor prothrombin complex concentrate (Kcentra) to treat severe acute bleeding in adults after administration...
more...
No comment yet.
Scooped by LGM Pharma
Scoop.it!

ESC issues "practical guide" to new oral anticoagulants in AF - TheHeart.Org

ESC issues "practical guide" to new oral anticoagulants in AF - TheHeart.Org | Apixaban | Scoop.it
ESC issues "practical guide" to new oral anticoagulants in AF TheHeart.Org It covers four new oral anticoagulants: the direct thrombin inhibitor dabigatran (Pradaxa, Boehringer Ingelheim) and the factor Xa inhibitors rivaroxaban (Xarelto,...
more...
No comment yet.
Scooped by LGM Pharma
Scoop.it!

EHRA Issues Guide for New Afib Drugs - MedPage Today - MedPage Today

EHRA Issues Guide for New Afib Drugs - MedPage Today - MedPage Today | Apixaban | Scoop.it
EHRA Issues Guide for New Afib Drugs - MedPage Today
MedPage Today
Apixaban (Eliquis) -- factor Xa inhibitor, doses 5 and 2.5 mg bid, pivotal trials: ARISTOTLE and AVERROES.
more...
No comment yet.
Scooped by LGM Pharma
Scoop.it!

FDA approves PCC to reverse warfarin-induced acute bleeding : Cardiology News

FDA approves PCC to reverse warfarin-induced acute bleeding : Cardiology News | Apixaban | Scoop.it
The Food and Drug Administration has approved a new agent – Kcentra (Prothrombin Complex Concentrate, Human) – for the urgent reversal of vitamin K antagonist (VKA) anticoagulation in adults with acute major bleeding.
more...
No comment yet.